The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
University of Texas Southwestern Medical Center · NCT06656819
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–39 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- July 1, 2020
- Record last updated
- March 30, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this project is to test our central hypothesis that the spinal cord neuroplasticity in females will be modulated by the level of estradiol concentration. under aim 1 we will determine the influence of estradiol fluctuations on spinal circuit excitability post afferent (sensory) mediated subthreshold motor priming in young healthy females and males. We will use an established repetitive peripheral nerve electrical stimulation with a stimulation intensity below the motor threshold to prime the spinal motor circuits. under aim 2 we seek to characterize the input output property of spinal circuit excitability after descending drive (motor) mediated priming in young healthy male participants. in aim 3 we will examine the influence of estradiol fluctuations on descending drive mediated motor priming in young healthy females.
Being studied: Magstim Rapid2
Conditions: Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
FEMALES
Inclusion Criteria
- Ages 18-39 years
- Eumenorrheic (regular monthly cycles of 24-35 days)
- Moderately active (less than 7 hours of vigorous physical activity per week)
- History of pregnancy is allowed if patient is in post-lactation phase
Exclusion Criteria
- History of musculoskeletal or orthopedic injury of the spine, hip, knee, ankle or foot
- History of neurological injury of the peripheral or central nervous system
- Current smoker
- History of disordered eating
- History of stress fracture in the lower limb
- History of a connective tissue disorder (Marfan's syndrome, Ehlers-Danlos disease)
- Pacemaker, metal implants in the head and spine region
- Pregnancy
- On a hormonal contraceptive regimen (oral, transdermal or vaginal)
- History of menstrual dysfunction (primary or secondary amenorrhea, oligomenorrhea, anovulatory cycles, polycystic ovarian disease)
- Started or stopped taking oral contraceptives within the previous 6 months
- Exercise vigorously more than 7 hours per week or currently participating in competitive level sports.
MALES
Inclusion Criteria
- Ages 18-39
- Moderately active (less than 7 hours of vigorous physical activity per week)
Exclusion Criteria
- History of musculoskeletal or orthopedic injury of the spine, hip, knee, ankle or foot
- History of neurological injury of the peripheral or central nervous system
- Current smoker
- History of disordered eating
- History of stress fracture in the lower limb
- History of a connective tissue disorder (Marfan's syndrome, Ehlers-Danlos disease)
- Pacemaker, metal implants in the head and spine region
Recruiting US locations
University of Texas Southwestern Medical Center
Dallas, TX 75390
Site contact: Yu-Chen Chung, PT, Ph.D.
Study contacts (from the official record)
- Yu-Chen Chung, PT, Ph.D. · 214-648-8838 · yu-chen.chung@utsouthwestern.edu
- Subaryani Soedirdjo, Ph.D. · subaryani.soedirdjo@utsouthwestern.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75